{"schema_version":"secwatch.filing_event.v1","accession":"0000320017-24-000013","form_type":"8-K","ticker":"LSTA","cik":"0000320017","company_name":"LISATA THERAPEUTICS, INC.","filed_at":"2024-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.544780+00:00","generated_at":"2026-06-03T21:55:16.345832+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Lisata appoints James Nisco as SVP, Finance & Treasury and CAO","bullets":["James Nisco appointed Senior Vice President, Finance and Treasury and Chief Accounting Officer effective April 15, 2024.","Nisco will serve as principal financial officer and principal accounting officer.","Annual base salary set at $350,000 with a short-term incentive bonus target of 35% of base.","Nisco previously served as Vice President of Finance & Treasury since August 2020, an internal promotion.","No family relationships with directors/executives; no reportable transactions under Item 404."],"urls":{"canonical":"https://secwatch.observer/filing/0000320017-24-000013","json":"https://secwatch.observer/filing/0000320017-24-000013.json","markdown":"https://secwatch.observer/filing/0000320017-24-000013.md","text":"https://secwatch.observer/filing/0000320017-24-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/0000320017-24-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/clbs-20240415.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T21:55:16.345832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b5b208023d","claim":"James Nisco was appointed as Senior Vice President, Finance and Treasury and Chief Accounting Officer at LISATA THERAPEUTICS, INC..","evidence_excerpt":"On April 15, 2024 (the “Effective Date”), the Board of Directors (the “Board”) of Lisata Therapeutics, Inc. (the “Company”) appointed James Nisco as the Company’s Senior Vice President, Finance and Treasury and Chief Accounting Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/0000320017-24-000013-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Finance and Treasury and Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}